Monoclonal antibody or aspirin desensitization in NSAID-exacerbated respiratory disease (N-ERD)?

Nonsteroidal anti-inflammatory drug (NSAID)-exacerbated respiratory disease (N-ERD) is a clinical syndrome characterized by nasal polyposis, asthma, and intolerance to aspirin/NSAID. It affects approximately 15% cases of severe asthma, 10% of nasal polyps and 9% of rhinosinusitis. N-ERD results in a...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Broeck, Dorien, Steelant, Brecht, Scadding, Glenis, Hellings, Peter W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Allergy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10130434/
https://www.ncbi.nlm.nih.gov/pubmed/37123562
http://dx.doi.org/10.3389/falgy.2023.1080951

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10130434/
https://www.ncbi.nlm.nih.gov/pubmed/37123562
http://dx.doi.org/10.3389/falgy.2023.1080951

Ejemplares similares